Anxiety disorder
Anxiety disorders are a group of mental disorders characterized by significant and uncontrollable feelings of anxiety and fear. These feelings impair social, occupational, and personal functions to a degree that daily life becomes difficult. A person may experience physical symptoms like increased heart rate or chest pain alongside cognitive issues such as restlessness or difficulty concentrating. In casual conversation, people often use the words anxiety and fear interchangeably. Clinical usage draws a sharp line between them. Anxiety is an unpleasant emotional state where the cause is either not readily identified or perceived to be uncontrollable. Fear is defined as an emotional and physiological response to a recognized external threat. This distinction matters because it determines how doctors treat patients who feel overwhelmed by dread without a clear source.
Generalized anxiety disorder affects older adults more than any other age group. It involves long-lasting anxiety that is not focused on any one object or situation. Those with this condition experience non-specific persistent fear and worry about everyday matters. A diagnosis requires excessive worry for six months or more regarding family life, work, or health. Specific phobias represent the largest category of anxiety disorders worldwide. Between 5% and 12% of the population has specific phobias triggered by objects or situations ranging from animals to blood. Panic disorder features brief attacks of intense terror marked by trembling or confusion. These attacks peak in less than ten minutes but can last for several hours. Agoraphobia describes a fear of places where escape is difficult or help may be unavailable. Social anxiety disorder involves an intense fear of negative public scrutiny or embarrassment. Roughly 7% of American adults have social anxiety disorder, and over 75% experience symptoms in childhood.
Evolutionary psychiatry interprets anxiety as part of an evolved defensive system calibrated to potential threat. The smoke-alarm principle suggests these mechanisms err on the side of false alarms. The cost of unnecessary fear is typically lower than the cost of failing to detect genuine danger. This framework extends to modern settings where mismatch between ancestral and contemporary threat profiles contributes to chronic anxiety. Anxiety mechanisms function like a sensor that prioritizes survival over accuracy. When the brain perceives a threat, it triggers a fight-or-flight response even if no immediate danger exists. This calibration helps ancestors survive predators but creates challenges in today's complex environments. Chronic or generalized anxiety often stems from this ancient system reacting to modern stressors. The body prepares for battle against a tiger when facing a deadline at work.
The diagnosis of anxiety disorders relies on symptoms, triggers, and personal family histories rather than objective biomarkers. No laboratory test can definitively diagnose anxiety. Medical professionals must evaluate patients to rule out underlying medical causes like thyroid disease or heart conditions. Many organizations support routinely screening all adults younger than 65 years old. Questionnaires developed for clinical use include the State-Trait Anxiety Inventory and the Generalized Anxiety Disorder 7 scale. The GAD-7 has a sensitivity ranging from 57% to 94% in diagnosing general anxiety disorder. Symptoms must be present for at least six months and occur more days than not. They significantly impair a person's ability to function in daily life. Screening questionnaires provide an objective scoring system but require follow-up with a clinical interview. Doctors assess impairment, distress, avoidance behaviors, and symptom history to make a final determination.
Cognitive behavioral therapy is effective for anxiety disorders and serves as a first-line treatment option. It is the most widely studied form of psychotherapy for these conditions. CBT appears equally effective whether carried out via the internet or completed face-to-face. Specific curriculums exist for each type of anxiety disorder. A meta-analysis showed medium to large benefit effect sizes for generalized anxiety disorder and panic disorder. Sessions are sometimes given once weekly for eight to twenty weeks. Booster sessions may need restarting if symptoms relapse. Mindfulness-based programs also appear effective for managing anxiety disorders. Exposure and response prevention has been found effective for treating obsessive-compulsive disorder. Art and play therapy allow children to express emotions they cannot verbally communicate. Family therapy involves meeting with primary guardians and siblings to address issues collectively.
First-line choices for medications include SSRIs or SNRIs to treat generalized anxiety disorder or social anxiety disorder. For adults there is no good evidence supporting which specific medication in these classes is best so cost often drives drug choice. Benzodiazepines serve as a second line option for pharmacologic treatment of anxiety. They have an onset usually within one week but carry risks of physical dependence and cognitive impairment. Clonazepam has a longer half life and may possibly be used as once per day dosing. Buspirone and pregabalin are second-line treatments for people who do not respond to first-line options. Adherence problems are more likely among older people who may have difficulty understanding instructions. Medications need to be used with care among older adults due to coexisting physical disorders. In 2007 data were sparse for the efficacy of any drug for specific phobias.
Globally as of 2010 approximately 273 million people had an anxiety disorder representing 4.5% of the population. It is more common in females at 5.2% than males at 2.8%. In Europe Africa and Asia lifetime rates of anxiety disorders are between 9% and 16%. The United States shows a lifetime prevalence of about 29% with 11% to 18% of adults having the condition yearly. Between 10% and 20% of all children develop a full-fledged anxiety disorder prior to age 18. Anxiety represents the most common mental health issue in young people. Children often interpret emotions physically as stomachaches or headaches leading to misdiagnosis. Gifted children are also often more prone to excessive anxiety than non-gifted children. People ranking highly in hypercompetitive traits face increased risk of both anxiety and depression according to a 2011 study.
Up Next
Continue Browsing
Common questions
What is anxiety disorder and how does it affect daily life?
Anxiety disorders are a group of mental disorders characterized by significant and uncontrollable feelings of anxiety and fear. These feelings impair social, occupational, and personal functions to a degree that daily life becomes difficult.
Which age group is most affected by generalized anxiety disorder?
Generalized anxiety disorder affects older adults more than any other age group. It involves long-lasting anxiety that is not focused on any one object or situation.
How do doctors diagnose anxiety disorders without laboratory tests?
The diagnosis of anxiety disorders relies on symptoms, triggers, and personal family histories rather than objective biomarkers. No laboratory test can definitively diagnose anxiety so medical professionals must evaluate patients to rule out underlying medical causes like thyroid disease or heart conditions.
What medications treat first-line cases of anxiety disorder?
First-line choices for medications include SSRIs or SNRIs to treat generalized anxiety disorder or social anxiety disorder. Benzodiazepines serve as a second line option for pharmacologic treatment of anxiety but carry risks of physical dependence and cognitive impairment.
How many people globally had an anxiety disorder in 2010?
Globally as of 2010 approximately 273 million people had an anxiety disorder representing 4.5% of the population. It is more common in females at 5.2% than males at 2.8%.